Cynata Therapeutics Limited

ASX:CYP Stok Raporu

Piyasa değeri: AU$42.5m

Cynata Therapeutics Yönetim

Yönetim kriter kontrolleri 3/4

Cynata Therapeutics' CEO is Kilian Kelly, appointed in Jul 2023, has a tenure of 1.33 years. total yearly compensation is A$544.83K, comprised of 71.7% salary and 28.3% bonuses, including company stock and options. directly owns 0.34% of the company’s shares, worth A$145.62K. The average tenure of the management team and the board of directors is 2.2 years and 4.4 years respectively.

Anahtar bilgiler

Kilian Kelly

İcra Kurulu Başkanı

AU$544.8k

Toplam tazminat

CEO maaş yüzdesi71.7%
CEO görev süresi1.3yrs
CEO sahipliği0.3%
Yönetim ortalama görev süresi2.2yrs
Yönetim Kurulu ortalama görev süresi4.4yrs

Son yönetim güncellemeleri

Recent updates

Here's Why We're Watching Cynata Therapeutics' (ASX:CYP) Cash Burn Situation

Sep 21
Here's Why We're Watching Cynata Therapeutics' (ASX:CYP) Cash Burn Situation

Will Cynata Therapeutics (ASX:CYP) Spend Its Cash Wisely?

May 29
Will Cynata Therapeutics (ASX:CYP) Spend Its Cash Wisely?

We're A Little Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn Rate

Feb 09
We're A Little Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn Rate

We're Interested To See How Cynata Therapeutics (ASX:CYP) Uses Its Cash Hoard To Grow

Feb 02
We're Interested To See How Cynata Therapeutics (ASX:CYP) Uses Its Cash Hoard To Grow

We Think Cynata Therapeutics (ASX:CYP) Can Easily Afford To Drive Business Growth

Sep 09
We Think Cynata Therapeutics (ASX:CYP) Can Easily Afford To Drive Business Growth

Here's Why We're Not At All Concerned With Cynata Therapeutics' (ASX:CYP) Cash Burn Situation

May 26
Here's Why We're Not At All Concerned With Cynata Therapeutics' (ASX:CYP) Cash Burn Situation

Here's Why We're Not Too Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn Situation

Dec 31
Here's Why We're Not Too Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn Situation

We're Not Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn

Aug 11
We're Not Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn

CEO Tazminat Analizi

Kilian Kelly'un ücretlendirmesi Cynata Therapeutics'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024AU$545kAU$391k

-AU$10m

Mar 31 2024n/an/a

-AU$12m

Dec 31 2023n/an/a

-AU$14m

Sep 30 2023n/an/a

-AU$14m

Jun 30 2023AU$413kAU$334k

-AU$14m

Mar 31 2023n/an/a

-AU$12m

Dec 31 2022n/an/a

-AU$9m

Sep 30 2022n/an/a

-AU$7m

Jun 30 2022AU$499kAU$313k

-AU$5m

Mar 31 2022n/an/a

-AU$5m

Dec 31 2021n/an/a

-AU$4m

Sep 30 2021n/an/a

-AU$6m

Jun 30 2021AU$737kAU$300k

-AU$8m

Mar 31 2021n/an/a

-AU$7m

Dec 31 2020n/an/a

-AU$6m

Sep 30 2020n/an/a

-AU$5m

Jun 30 2020AU$472kAU$300k

-AU$4m

Mar 31 2020n/an/a

-AU$6m

Dec 31 2019n/an/a

-AU$8m

Sep 30 2019n/an/a

-AU$8m

Jun 30 2019AU$449kAU$279k

-AU$8m

Mar 31 2019n/an/a

-AU$7m

Dec 31 2018n/an/a

-AU$6m

Sep 30 2018n/an/a

-AU$5m

Jun 30 2018AU$357kAU$259k

-AU$5m

Tazminat ve Piyasa: Kilian's total compensation ($USD357.15K) is about average for companies of similar size in the Australian market ($USD299.27K).

Tazminat ve Kazançlar: Kilian's compensation has increased whilst the company is unprofitable.

CEO

Kilian Kelly

1.3yrs

Görev süresi

AU$544,827

Tazminat

Dr. Kilian Kelly has been Chief Executive Officer and Managing Director at Cynata Therapeutics Limited since July 1, 2023 and has been its Director since 2023 and had been its Chief Operating Officer since...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Kilian Kelly
MD, CEO & Director1.3yrsAU$544.83k0.34%
A$ 145.6k
Jolanta Airey
Chief Medical Officer3.1yrsAU$398.72kVeri yok
Mathias Kroll
Chief Business Officerless than a yearAU$379.02kVeri yok
Peter Webse
Company Secretary12.6yrsAU$140.00kVeri yok

2.2yrs

Ortalama Görev Süresi

Deneyimli Yönetim: CYP's management team is considered experienced (2.2 years average tenure).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Kilian Kelly
MD, CEO & Director1.8yrsAU$544.83k0.34%
A$ 145.6k
Geoffrey Edward Brooke
Independent Non-Executive Chairman5.5yrsAU$138.77k0.14%
A$ 60.5k
Paul Wotton
Independent Non-Executive Director8.4yrsAU$68.20k0.17%
A$ 74.1k
Janine Rolfe
Independent Non-Executive Director2.2yrsAU$81.69k0.064%
A$ 27.3k
Darryl Maher
Independent Non-Executive Director4.4yrsAU$68.20k0.028%
A$ 11.7k

4.4yrs

Ortalama Görev Süresi

64yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: CYP's board of directors are considered experienced (4.4 years average tenure).